HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Personal Folders Download to citation manager Permission Requests Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Cohn, L. H. Articles by Collins, J. J. Search for Related Content PubMed PubMed Citation Articles by Cohn, L. H. Articles by Collins, J. J., Jr

The Journal of Thoracic and Cardiovascular Surgery, Vol 90, 872-881, Copyright © 1985 by The American Association for Thoracic Surgery and The Western Thoracic Surgical Association

ARTICLES

Early and late risk of mitral valve replacement. A 12 year concomitant comparison of the porcine bioprosthetic and prosthetic disc mitral valves

LH Cohn, EN Allred, LA Cohn, JC Austin, J Sabik, VJ DiSesa, RJ Shemin and JJ Collins Jr

A consecutive series of 706 mitral valve replacements was performed from January, 1972, to January, 1984. The follow-up ranged from 6 to 150 months with a mean of 50 and a median of 43 months. Seven percent (50) of the patient were lost to follow-up. There were 243 men and 463 women, whose ages ranged from 17 to 86 years (mean 58). A porcine bioprosthetic valve was implanted in 528 patients (514 Hancock and 14 Carpentier-Edwards valves) and a prosthetic disc valve in 178 patients (102 standard disc Bjork-Shiley, 34 Beall, and 42 Harken disc valves). Seven patients were in Functional Class II, 325 in Class III, and 374 in Class IV. A concomitant operative procedure was performed in 253 of the 706 patients (36%). Mitral regurgitation was the primary hemodynamic lesion in 363 and mitral stenosis in 343. Operative mortality figures were as follows: 77 of 706 (11%) for the overall group, 34 of 453 (7.5%) for isolated mitral valve replacement, 30 of 169 (17.5%, p = 0.001) for mitral replacement plus coronary bypass, 49 of 528 (9%) for the bioprosthetic valve group, and 28 of 178 (16%) for the prosthetic disc valve group (p = 0.01). After the operation, 262 patients were in Functional Class I, 99 in Class II, and 18 in Class III. The long-term survival rate was significantly lower in patients who had an associated procedure (45% +/- 6%), who had mitral regurgitation rather than mitral stenosis (53% +/- 5% versus 67% +/- 4%) (p = 0.002), who were in Functional Class IV rather than Classes I to III (51% +/- 4% versus 70% +/- 4%) (p = 0.001), and who received a prosthetic disc valve rather than a bioprosthesis (40% +/- 6% versus 67% +/- 4%) (p = 0.001). Thromboembolic rates were significantly higher with prosthetic valves than with bioprosthetic valves (4.6% +/- 0.22% versus 2.4% +/- 0.5% per patient-year of follow-up), and the incidence of anticoagulant-related hemorrhage was significantly higher in the prosthetic valve group (1.65% versus 0.43% per patient-year). Primary valve dysfunction was significantly more common in the bioprostheses (1.23% versus 0.40% per patient-year).(ABSTRACT TRUNCATED AT 400 WORDS)

This article has been cited by other articles:

				T. Gudbjartsson, T. Absi, and S. Aranki Mitral Valve Replacement Card. Surg. Adult, January 1, 2008; 3(2008): 1031 - 1068. [Full Text]

				T. Gudbjartsson, S. Aranki, and L. H. Cohn Mechanical/Bioprosthetic Mitral Valve Replacement Card. Surg. Adult, January 1, 2003; 2(2003): 951 - 986. [Full Text]

				B. C. Astor, R. G. Kaczmarek, B. Hefflin, and W. R. Daley Mortality after aortic valve replacement: results from a nationally representative database Ann. Thorac. Surg., December 1, 2000; 70(6): 1939 - 1945. [Abstract] [Full Text] [PDF]

				I. G. Duarte, Y. Shen, M. J. MacDonald, E. L. Jones, J. M. Craver, and R. A. Guyton Treatment of moderate mitral regurgitation and coronary disease by coronary bypass alone: late results Ann. Thorac. Surg., August 1, 1999; 68(2): 426 - 430. [Abstract] [Full Text] [PDF]

				K. P. Rao and C. Shanthi Reduction of Calcification by Various Treatments in Cardiac Valves J Biomater Appl, January 1, 1999; 13(3): 238 - 268. [Abstract] [PDF]

				M. R. Aupart, P. H. Neville, S. Hammami, A. L. Sirinelli, Y. A. Meurisse, and M. A. Marchand CARPENTIER-EDWARDS PERICARDIAL VALVES IN THE MITRAL POSITION: TEN-YEAR FOLLOW-UP J. Thorac. Cardiovasc. Surg., March 1, 1997; 113(3): 492 - 498. [Abstract] [Full Text]

				J. J. Vincens, D. Temizer, J. R. Post, L. H. Edmunds Jr, and H. C. Herrmann Long-term Outcome of Cardiac Surgery in Patients With Mitral Stenosis and Severe Pulmonary Hypertension Circulation, November 1, 1995; 92(9): 137 - 142. [Abstract] [Full Text]

				M. Enriquez-Sarano, H. V. Schaff, T. A. Orszulak, K. R. Bailey, A. J. Tajik, and R. L. Frye Congestive Heart Failure After Surgical Correction of Mitral Regurgitation : A Long-term Study Circulation, November 1, 1995; 92(9): 2496 - 2503. [Abstract] [Full Text]

				M. Enriquez-Sarano, H. V. Schaff, T. A. Orszulak, A. J. Tajik, K. R. Bailey, and R. L. Frye Valve Repair Improves the Outcome of Surgery for Mitral Regurgitation : A Multivariate Analysis Circulation, February 15, 1995; 91(4): 1022 - 1028. [Abstract] [Full Text]

				D. D. Glower, W. D. White, A. C. Hatton, L. R. Smith, W. G. Young, W. G. Wolfe, and J. E. Lowe Determinants of reoperation after 960 valve replacements with Carpentier-Edwards prostheses J. Thorac. Cardiovasc. Surg., February 1, 1994; 107(2): 381 - 393. [Abstract] [Full Text]

				J.F. Lopez, B. Bharadwaj, and S. Lal Experience with Hall-Kaster Valves Vascular and Endovascular Surgery, January 1, 1990; 24(1): 16 - 22. [Abstract] [PDF]